Autoimmune lymphoproliferative syndrome (ALPS) caused by Fas (CD95) mutation mimicking sarcoidosis

American Journal of Surgical Pathology

Volumn 32, Issue 2, 2008, Pages 329-334

  Müllauer, Leonhard ^a   Emhofer, Josef ^b   Wohlfart, Sabine ^a   Pichlhöfer, Bettina ^a   Stary, Susanne ^a   Ebetsberger, Georg ^c   Mannhalter, Christine ^a   Chott, Andreas ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b General Hospital Steyr   (Austria)

^c KEPLER UNIVERSITY HOSPITAL   (Austria)

Author keywords

ALPS; Fas (CD95); Sarcoidosis

Indexed keywords

FAS ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANAMNESIS; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CELL DEATH; CELL INFILTRATION; CHILD; CLINICAL EXAMINATION; CLINICAL FEATURE; CLONAL VARIATION; DIAGNOSTIC ACCURACY; FEMALE; GENE MUTATION; GENE SEQUENCE; HISTIOCYTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LYMPHOPROLIFERATIVE DISEASE; MISSENSE MUTATION; SARCOIDOSIS; SEQUENCE ANALYSIS; THORAX RADIOGRAPHY;

ADOLESCENT; ANTIGENS, CD95; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HISTIOCYTOSIS, SINUS; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPH NODES; LYMPHOPROLIFERATIVE DISORDERS; MUTATION, MISSENSE; SARCOIDOSIS; SEQUENCE ANALYSIS, DNA;

EID: 38649088596     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181484f6d     Document Type: Article

References (23)

1. Brown NJ, Hutcheson J, Bickel E, et al. Fas death receptor signaling represses monocyte numbers and macrophage activation in vivo. J Immunol. 2004;173:7584-7593.
2. Canale VC, Smith CH. Chronic lymphadenopathy simulating malignant lymphoma. J Pediatr. 1967;70:891-899.
3. Chun HJ, Zheng L, Ahmad M, et al. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature. 2002;419:395-399.
4. Del-Rey M, Ruiz-Contreras J, Bosque A, et al. A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome. Blood. 2006;108:1306-1312.
5. Eslick J, Scatizzi JC, Albee L, et al. IL-4 and IL-10 inhibition of spontaneous monocyte apoptosis is associated with Flip upregulation. Inflammation. 2004;28:139-145.
6. Fisher GH, Rosenberg FJ, Straus SE, et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell. 1995;81:935-946.
7. Födinger M, Winkler K, Mannhalter C, et al. Combined polymerase chain reaction approach for clonality detection in lymphoid neoplasms. Diagn Mol Pathol. 1999;8:80-91.
8. Foucar E, Rosai J, Dorfman R. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfmann disease): review of the entity. Semin Diagn Pathol. 1990;7:19-73.
9. Fuss IJ, Strober W, Dale JK, et al. Characteristic T helper 2T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity. J Immunol. 1997;158:1912-1918.
10. Holzelova E, Vonarbourg C, Stolzenberg MC, et al. Autoimmune lymphoproliferative syndrome with somatic Fas mutations. N Engl J Med. 2004;351:1409-1418.
11. Huang B, Eberstadt M, Olejniczak ET, et al. NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain. Nature. 1996;384:638-641.
12. Lim MS, Straus SE, Dale JK, et al. Pathological findings in human autoimmune lymphoproliferative syndrome. Am J Pathol. 1998;153:1541-1550.
13. Lopatin U, Yao X, Williams RK, et al. Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression. Blood. 2001;97:3161-3170.
14. Maric I, Pittaluga S, Dale JK, et al. Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome. Am J Surg Pathol. 2005;29:903-911.
15. Ohga S, Nomura A, Takahata Y, et al. Dominant expression of interleukin 10 but not interferon gamma in CD4(-) CD8(-)alphabetaT cells of autoimmune lymphoproliferative syndrome. Br J Haematol. 2002;119:535-538.
16. Rieux-Laucat F, Le Deist F, Hivroz C, et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science. 1995;268:1347-1349.
17. Straus SE, Jaffe ES, Puck JM, et al. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood. 2001;98:194-200.
18. Wang J, Zheng L, Lobito A, et al. Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell. 1999;98:47-58.
19. Watanabe-Fukunaga R, Brannan CI, Copeland NG, et al. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 1992;356:314-317.
20. Wohlfart S, Sebinger D, Gruber P, et al. Fas (CD95) mutations are rare in gastric MALT lymphoma but occur more frequently in primary gastric diffuse large B-cell lymphoma. Am J Pathol. 2004;164:1081-1089.
21. Worth A, Thrasher AJ, Gaspar HB. Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype. Br J Haematol. 2006;133:124-140.
22. Wu J, Wilson J, He J, et al. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest. 1996;98:1107-1113.
23. Zhu S, Hsu AP, Vacek MM, et al. Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome. Hum Genet. 2006;119:284-294.